FDA Panel Pans HIFU for Prostate CancerFDA Panel Pans HIFU for Prostate Cancer

An FDA advisory committee recommended against approval of high-intensity focused ultrasound (HIFU) for prostate cancer because of 'murkiness' of data. Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news